Navigation Links
Iowa Scientist's AI Device to Complete FDA Clinical Trial
Date:7/5/2017

Media Contact:
Laura Shoemaker
Marketing Communications Manager
1-319-248-5620
lshoemaker(at)eyediagnosis.net

Iowa scientist's AI device to complete FDA clinical trial

An Iowa scientist's first AI device is scheduled to complete a rigorous FDA clinical trial by the end of summer 2017. Dr. Michael Abramoff, a world-renowned retina specialist who lives in Iowa City, has spent the past 20 years developing IDx-DR, an automated screening solution designed to detect diabetic eye disease.

“I’ve worked on this for so long because I strongly believe automation will have a transformative impact on healthcare,” said Abramoff, a practicing ophthalmologist at University of Iowa Hospitals & Clinics and the Iowa City VA Health Care System. “Finishing the clinical trial means that we are one step closer to touching patients’ lives.”

The clinical trial is taking place at 10 sites across 7 states and will involve more than 850 patients with diabetes. Participants agree to have images of their eyes captured and submitted to the IDx-DR software, which uses an algorithm to scan for signs of diabetic retinopathy, one of the leading causes of blindness among working age adults.

According to the American Diabetes Association, the current standard of care is for people with diabetes to have an annual eye exam. However, due to cost and inconvenience, nearly half of those with diabetes are not regularly screened for diabetic retinopathy, putting them at risk of losing their vision.

“Too many patients go blind needlessly because they aren’t diagnosed in time,” said Abramoff. “If we can put IDx-DR in the hands of primary care providers, it has the potential to increase early detection so that patients with disease can be referred to a specialist for treatment.”

Abramoff and his colleagues developed IDx-DR specifically for use in the frontlines of care, so that patients with diabetes can have their eyes checked for diabetic retinopathy during routine office visits.

Over the past two decades, Abramoff has earned a reputation as the most widely published researcher in the field of automated disease detection of the eye. His work has generated over 17 patents, scores of peer-reviewed journal publications, and significant commercialization investments.

IDx products have not been cleared by the FDA and are not currently for sale in the United States. IDx recently released IDx-DR version 2.0, a secure cloud version of the software, which has received its CE mark as a Class IIa Medical Device for sale in the European Union.

About IDx, LLC
IDx is an early-stage medical device company focused on developing software-based algorithms that can identify disease in medical images. Its mission is to transform the quality, accessibility, and affordability of global healthcare through the automation of medical diagnosis and treatment.

IDx is a leader in automated medical image analysis. The company is currently conducting an FDA clinical trial to obtain clearance for its first product, IDx-DR, a screening solution for diabetic retinopathy. IDx also has algorithms in development for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk. The company was founded by world renowned retina specialists at the University of Iowa Hospitals & Clinics and has a strategic alliance with IBM Watson Health to distribute its products in the EU.

IDx, LLC
485 Highway 1 West
Iowa City, IA 52246
Phone: 319-248-5620
http://www.eyediagnosis.net
###

Read the full story at http://www.prweb.com/releases/2017/07/prweb14483348.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. FDAnews Announces — New Brief — Device Accessories: Understanding and Implementing FDA’s Guidance
2. FDAnews Announces — New Management Report — Drug or Device? How the 21st Century Cures Act Impacts Combination Products
3. FDAnews Announces — New Book — Guide to FDA and EU Medical Device Regulations: 2017 Edition
4. Molecular Devices Launches ImageXpress Nano System and CellReporterXpress Software
5. FDA Clearance Granted to QT Ultrasound® for New Breast Imaging Device
6. Polysense Introduces First Universal Sensing Node Product Line Based on Semtech’s LoRa® Devices and Wireless RF Technology
7. Inventor and InventHelp Client Develops First-Aid Choking Device (SFO-369)
8. NetZoom™ Visio® Stencils Library Updated for Data Center and Network Devices from Ciena, Raritan, Nokia, Juniper and More Manufacturers
9. Sanford Surgeon, Boston Scientific Collaborate to Develop Device
10. Dr. Kevin Sadati Announces State-Of-The Art, FDA-Cleared Vivace Microneedling Radio Frequency Device Now Available To Patients
11. Orbita and ERT Collaborate to Optimize Data Capture, Insights for Pharmaceutical and Device Trials via Amazon Echo-based Voice Assistants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at ... , Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with website ... Awards to be consumer voted. The Magic Wand Rechargeable won in stiff competition ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality ... Consulting **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early ... FDA scrutiny and growing demands to track and report adverse events place even ...
(Date:7/24/2017)... Island (PRWEB) , ... July 24, 2017 , ... ... a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The ... Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... ... “A Short Walk to the Mailbox”: a remarkable memoir of an unconventional ... Ed Clark. Ed Clark is a church music director and choral conductor. ... music and worship leader for over fifty years. He has a master’s degree ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology: